Patent · US Active

Compositions and methods for modulating hemostasis

US8999322B2 · kind B2 · utility

0Cited by

1References

7Claims

0Family size

Assignee

THE UNITED STATES OF AMERICA NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR) · US

Inventors

Sriram Krishnaswamy · Fremont, US
Elsa Bianchini · Philadelphia, US
Steven J. Orcutt · Audubon, US

Key dates

Filing date	Dec 10, 2012
Grant date	Apr 7, 2015
Priority date	—
Expiry date	Dec 10, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y304/21005
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Novel thrombin/prothrombin protease/zymogen variants which have anticoagulation activity and methods of use thereof are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.